Risk of exposure to blood products during pregnancy: guidance for Zika and other donor deferral policies

Transfusion

Volumn 57, Issue 3, 2017, Pages 811-815

  Murphy, Malia S Q ^a   Shehata, Nadine ^b   Colas, Jo Ann ^a   Chassé, Michaël ^c,d   Fergusson, Dean A ^a,e   O'Brien, Sheila F ^f   Goldman, Mindy ^f   Tinmouth, Alan ^a,e   Forster, Alan J ^a,e   Wilson, Kumanan ^a,e  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f CANADIAN BLOOD SERVICES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; FEMALE; FIRST TRIMESTER PREGNANCY; HEALTH CARE POLICY; HUMAN; INFECTION RISK; INTRAUTERINE BLOOD TRANSFUSION; LIVE BIRTH; MATERNAL EXPOSURE; PREGNANCY; PREGNANT WOMAN; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; STILLBIRTH; TERTIARY CARE CENTER; THIRD TRIMESTER PREGNANCY; VIRUS TRANSMISSION; ZIKA VIRUS; ADULT; BLOOD COMPONENT THERAPY; DONOR SELECTION; EPIDEMIOLOGY; PREGNANCY COMPLICATIONS, INFECTIOUS; TRANSMISSION; ZIKA VIRUS INFECTION;

ADULT; BLOOD COMPONENT TRANSFUSION; DONOR SELECTION; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; STILLBIRTH; TERTIARY CARE CENTERS; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 85012992044     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.14001     Document Type: Article

References (23)

1. Petrakos G, Andriopoulos P, Tsironi M. Pregnancy in women with thalassemia: challenges and solutions. Int J Womens Health 2016;8:441-51.
2. Pozzetto B, Memmi M, Garraud O. Is transfusion-transmitted dengue fever a potential public health threat? World J Virol 2015;4:113-23.
3. Prevent dengue during pregnancy [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; [cited 2016 Nov 03]. Available from: http://www.cdc.gov/dengue/resources/educationmaterials_pdfs/15_261427-a_seda_508_update_prevent_dengue_during_pregnancy508.pdf.
4. New blood donation rules protect Canadian blood supply from Zika virus [press release]. Ottawa: Canadian Blood Services; 2016 Feb 3.
5. Revised recommendations for reducing the risk of Zika virus transmission by blood and blood components: guidance for industry [Internet]. Silver Spring (MD): U.S. Food and Drug Administration, U.S. Department of Health and Human Services; 2016 [cited 2016 Nov 27]. Available from: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/UCM518213.pdf.
6. WHO statement on the first meeting of the International Health Regulations (2005) (IHR 2005) Emergency Committee on Zika Virus and Observed Increase in Neurological Disorders and Neonatal Malformations [press release]. Geneva: World Health Organization; 2016 Feb 1.
7. Zika situation report. Zika virus, microcephaly, Guillain-Barré syndrome. [Internet]. Geneva: World Health Organization; 2016 [cited 2016 Aug 25]. Available from: http://www.who.int/emergencies/zika-virus/situation-report/29-december-2016/en/.
8. Possible association between Zika virus infection and microcephaly—Brazil, 2015 [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2016 [cited 2016 Aug 25]. Available from: http://www.cdc.gov/mmwr/volumes/65/wr/mm6503e2.htm.
9. Zika virus infection: Global Update [Internet]. Government of Canada; 2016 [cited 2017 Jan 03]. Available from: https://travel.gc.ca/travelling/health-safety/travel-health-notices/152.
10. Barjas-Castro ML, Angerami RN, Cunha MS, et al. Probable transfusion-transmitted Zika virus in Brazil. Transfusion 2016;56:1684-8.
11. Motta IJ, Spencer BR, Cordeiro Da Silva SG, et al. Evidence for transmission of Zika virus by platelet transfusion. N Engl J Med 2016;375:1101-3.
12. Chasse M, Tinmouth A, English SW, et al. Association of blood donor age and sex with recipient survival after red blood cell transfusion. JAMA Intern Med 2016;176:1307-14.
13. Shehata N, Forster A, Lawrence N, et al. Changing trends in blood transfusion: an analysis of 244,013 hospitalizations. Transfusion 2014;54(10 Pt 2):2631-9.
14. Shehata N, Forster AJ, Lawrence N, et al. Transfusion patterns in all patients admitted to the intensive care unit and in those who die in hospital: a descriptive analysis. PLoS One 2015;10:e0138427.
15. Johansson MA, Mier-Y-Teran-Romero L, Reefhuis J, et al. Zika and the risk of microcephaly. N Engl J Med 2016;375:1-4.
16. Cauchemez S, Besnard M, Bompard P, et al. Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study. Lancet 2016;387:2125-32.
17. Leach Bennett J, Blajchman MA, Delage G, et al. Proceedings of a consensus conference: risk-based decision making for blood safety. Transfus Med Rev 2011;25:267-92.
18. Pendry K. The use of big data in transfusion medicine. Transfus Med 2015;25:129-37.
19. O'Brien SF, Devine D, Goldman MR, et al. Estimated risk to the Canadian blood supply from sexually transmitted Zika virus [abstract]. Transfusion 2016;56:12A.
20. U.S. FoodFDA advises testing for Zika virus in all donated blood and blood components in the US [press release]. Silver Spring (MD): and Drug Administration; 2016 Aug 26.
21. Statement from Peter Marks, M.D., Ph.D., Director, FDA's Center for Biologics Evaluation and Research [press release]. Silver Spring (MD): U.S. Food and Drug Administration; 2016 Jul 28.
22. U.S. FoodFDA allows use of investigational test to screen blood donations for Zika virus [press release]. Silver Spring (MD): and Drug Administration; 2016 Mar 30.
23. Honein MA, Dawson AL, Peterson EE, et al. Birth defects among fetuses and infants of US women with evidence of possible Zika virus infection during pregnancy. JAMA 2017;317:59–68.